JMDC Inc
TSE:4483

Watchlist Manager
JMDC Inc Logo
JMDC Inc
TSE:4483
Watchlist
Price: 3 907 JPY -0.13% Market Closed
Market Cap: 255.4B JPY
Have any thoughts about
JMDC Inc?
Write Note

JMDC Inc
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

JMDC Inc
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
JMDC Inc
TSE:4483
Cash from Operating Activities
ÂĄ8.7B
CAGR 3-Years
30%
CAGR 5-Years
31%
CAGR 10-Years
N/A
M3 Inc
TSE:2413
Cash from Operating Activities
ÂĄ55.1B
CAGR 3-Years
6%
CAGR 5-Years
22%
CAGR 10-Years
19%
EM Systems Co Ltd
TSE:4820
Cash from Operating Activities
ÂĄ3.1B
CAGR 3-Years
46%
CAGR 5-Years
8%
CAGR 10-Years
9%
S
Software Service Inc
TSE:3733
Cash from Operating Activities
ÂĄ8.8B
CAGR 3-Years
23%
CAGR 5-Years
25%
CAGR 10-Years
9%
Medley Inc
TSE:4480
Cash from Operating Activities
ÂĄ3.9B
CAGR 3-Years
69%
CAGR 5-Years
82%
CAGR 10-Years
N/A
e
eWeLL Co Ltd
TSE:5038
Cash from Operating Activities
ÂĄ626.9m
CAGR 3-Years
47%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

JMDC Inc
Glance View

Market Cap
255.3B JPY
Industry
Health Care

Amidst the complex intersection of healthcare and technology, JMDC Inc. has carved a unique niche by harnessing the power of big data to improve healthcare outcomes and efficiency. Founded in Japan, the company stands as a beacon in the health informatics sector, meticulously collecting and analyzing health-related data drawn from a variety of sources, including medical claims, health screenings, and electronic health records. By transforming this extensive data trove into actionable insights, JMDC offers healthcare providers, pharmaceutical companies, and insurance firms the analytics they need to make informed decisions. Key to JMDC's operation is its commitment to safeguarding patient anonymity while extracting valuable insights that can streamline healthcare delivery, enhance pharmaceutical research, and optimize insurance underwriting. JMDC's revenue model hinges on the sale of its aggregated data and analytics solutions to a vast array of stakeholders in the medical field. Pharmaceutical companies, eager to understand drug efficacy and patient demographics better, turn to JMDC for data-driven insights that can influence drug development and marketing strategies. Insurance companies leverage JMDC's data to refine their offerings and better assess risk, ensuring competitive pricing models and improved customer satisfaction. Moreover, healthcare providers utilize this analytics backbone to enhance operational efficiency and improve patient care outcomes. Through licensing agreements and subscription-based services, JMDC effectively monetizes its data resources, achieving sustained growth in an industry that increasingly values the marriage of technology and healthcare.

Intrinsic Value
3 587.97 JPY
Overvaluation 8%
Intrinsic Value
Price

See Also

What is JMDC Inc's Cash from Operating Activities?
Cash from Operating Activities
8.7B JPY

Based on the financial report for Sep 30, 2024, JMDC Inc's Cash from Operating Activities amounts to 8.7B JPY.

What is JMDC Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
31%

Over the last year, the Cash from Operating Activities growth was 98%. The average annual Cash from Operating Activities growth rates for JMDC Inc have been 30% over the past three years , 31% over the past five years .

Back to Top